Rigel Pharmaceuticals Inc (RIGL)
16.04
-0.01
(-0.06%)
USD |
NASDAQ |
Oct 04, 16:00
16.05
+0.01
(+0.06%)
After-Hours: 20:00
Rigel Pharmaceuticals Revenue (Annual): 116.88M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 116.88M |
| December 31, 2022 | 120.24M |
| December 31, 2021 | 149.24M |
| December 31, 2020 | 108.62M |
| December 31, 2019 | 59.29M |
| December 31, 2018 | 44.51M |
| December 31, 2017 | 4.484M |
| December 31, 2016 | 20.38M |
| December 31, 2015 | 28.90M |
| December 31, 2014 | 8.25M |
| December 31, 2013 | 7.15M |
| December 31, 2012 | 2.25M |
| December 31, 2011 | 4.75M |
| Date | Value |
|---|---|
| December 31, 2010 | 125.00M |
| December 31, 2009 | 0.75M |
| December 31, 2008 | |
| December 31, 2007 | 12.60M |
| December 31, 2006 | 33.47M |
| December 31, 2005 | 16.53M |
| December 31, 2004 | 4.733M |
| December 31, 2003 | 11.06M |
| December 31, 2002 | 15.79M |
| December 31, 2001 | 15.30M |
| December 31, 2000 | 13.22M |
| December 31, 1999 | 8.984M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
59.29M
Minimum
2019
149.24M
Maximum
2021
110.85M
Average
116.88M
Median
2023
Revenue (Annual) Benchmarks
| Ionis Pharmaceuticals Inc | 787.65M |
| Collegium Pharmaceutical Inc | 566.77M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.490M |
| iBio Inc | 0.225M |